Skip to content
thispeptide

Iron Med RX

Iron Med RX is a longevity-branded telehealth that sells sermorelin, NAD+, glutathione, GHK-Cu and PT-141 in several forms, plus compounded GLP-1s. Every product shows a monthly price. None shows a dose.

Review by Molly Ward, goal-guide writer · Updated September 2026

The short version

Iron Med RX makes it easy to find a peptide and a starting price, and it promises regular check-ins and unlimited messaging once you are in. It is much less forthcoming about the medicine itself. No product page gives a dose or schedule, the prescribers go unnamed, and its outcome figures come from its own customer surveys.

Disclosure: This Peptide is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

Lowest listed: Glutathione injection, from $129/mo

Visit Iron Med RX →

Iron Med RX is a cash-pay online clinic that sells itself as a longevity platform. Its catalog runs to 45 products: compounded semaglutide and tirzepatide as injections and tablets, sermorelin, NAD+, glutathione, GHK-Cu and PT-141, and a long list of sleep and sexual-performance tablets that are not peptides.

What Iron Med RX prescribes, by goal

Weight

  • SemaglutideFDA-approved
    • Injection (compounded)From $149/mo
    • Oral (compounded)From $196/mo
  • TirzepatideFDA-approved
    • Injection (compounded)From $149/mo
    • Oral (compounded)From $249/mo

Compounded semaglutide and tirzepatide injections both start at $149 a month, with tablets from $196 and $249. No dose ladder is printed. The FAQ says a BMI of 30 or more is likely a fit and one under 25 is usually turned down.

Sexual health

PT-141 is an injection at $179 a month. Its page describes the effect on desire and prints no dose, schedule or approval status. GHK-Cu is sold as a skin cream at $179 a month and as tablets at $149, with no dose or strength printed for either.

Longevity

  • GlutathioneLegal to compound
    • Injection (compounded)From $129/mo
    • Oral (compounded)From $139/mo
  • NAD+Legal to compound
    • Injection (compounded)From $140/mo
    • Nasal spray (compounded)From $149/mo
    • Oral (compounded)From $199/mo

NAD+ comes as a 500 mg injection at $140 a month, a 1000 mg injection at $220, nasal sprays of 900 mg at $149 and 1200 mg at $199, and an oral form at $199. The pages print no dose per use or schedule, so it is unclear what the milligram figure covers. Glutathione is an injection at $129 a month or a daily oral at $139, again with no dose given.

Recovery

  • GHK-CuLegal to compound
    • Oral (compounded)From $149/mo
    • Topical (compounded)From $179/mo
  • SermorelinLegal to compound
    • Injection (compounded)From $149/mo
    • Oral (compounded)From $229/mo

Sermorelin is the product in this catalog that fits recovery, sold on the same plans as for sleep. The page claims it supports lean muscle and strength and cites no study.

Sleep

  • SermorelinLegal to compound
    • Injection (compounded)From $149/mo
    • Oral (compounded)From $229/mo

Sermorelin comes as an injection at $149 a month or as tablets at $229, each sold in a low-dose and a high-dose version. The pages print no dose in milligrams and no schedule; the words low and high are the only guide.

Prices are the seller’s own published starting figures, each in the unit the seller states. Compounded preparations are not FDA-approved.

Who prescribes

A licensed clinician

The site says its prescribers are US-licensed clinicians on a fully in-house team. It names two doctors as its medical review team, credited with reviewing protocols, but it does not name the clinicians who read your intake and write the prescription. Its terms also refer to "the licensed provider or provider network" involved in a review, which sits awkwardly beside the in-house claim.

You start with an online intake questionnaire: goals, state, date of birth, then an account and your medical history, with an ID and selfie check. A clinician reviews it and may follow up. Some states require a video visit before a prescription, and the FAQ says you can ask for one anywhere at no extra cost. After approval, the site promises regular check-ins, unlimited provider messaging and dose adjustments.

Are labs required?

Not mentioned

No page mentions labs. They are not listed as a requirement, an included test or an add-on, and the intake asks for your history rather than bloodwork.

Ready to start with Iron Med RX?

Lowest listed price: Glutathione injection, from $129/mo. Confirm it on the seller's own site.

Visit Iron Med RX →

What it claims, and what it cites

The headline figures are Iron Med RX's own survey results, and one of them says so: 82% of people noticing a benefit by their first check-in, self-reported by 162 customers. The NAD+ and glutathione pages print similar percentages with no source at all. The GLP-1 page puts weight loss in clinical studies at 0 to 20% without naming a study.

On Iron Med RX’s siteSource it gives
On Iron Med RX’s site“82% of people notice at least one benefit by their first check-in”Source it givesSelf-reported by 162 surveyed customers
On Iron Med RX’s site“85% Felt noticeable benefits in 30 days”Source it givesNone given
On Iron Med RX’s site“0-20% Average body weight reduction in clinical studies”Source it gives"Clinical studies", none named
On Iron Med RX’s site“11+ In-house longevity clinical trials informing every protocol”Source it givesNone given

Sold by Iron Med RX, not listed here

BPC-157
On no 503A list (removed from Category 2 in April 2026, never in Category 1). The FDA's compounding advisory committee voted 8–6 (one abstention) in July 2026 to favor listing it; the vote is a recommendation, not binding on the FDA, and pharmacies may not compound it until final rulemaking.
MOTS-c
On no 503A list (not in Categories 1–3 of the May 14, 2026 update). The FDA's compounding advisory committee voted 7–5 (two abstentions) in July 2026 to favor listing it; the vote is a recommendation, not binding on the FDA, and pharmacies may not compound it until final rulemaking.
Tesamorelin
Approved only as Egrifta, for excess abdominal fat in adults with HIV-associated lipodystrophy. Its label says it is not indicated for weight loss. Egrifta became a biologic (BLA) on March 23, 2020, and FDA says compounded versions of these products do not qualify for the 503A or 503B compounding exemptions.
BPC-157, alone, with TB-500 or in the GLOW blend
On no 503A list (removed from Category 2 in April 2026, never in Category 1). The FDA's compounding advisory committee voted 8–6 (one abstention) in July 2026 to favor listing it; the vote is a recommendation, not binding on the FDA, and pharmacies may not compound it until final rulemaking.
MOTS-c
On no 503A list (not in Categories 1–3 of the May 14, 2026 update). The FDA's compounding advisory committee voted 7–5 (two abstentions) in July 2026 to favor listing it; the vote is a recommendation, not binding on the FDA, and pharmacies may not compound it until final rulemaking.
Tesamorelin
Approved only as Egrifta, for excess abdominal fat in adults with HIV-associated lipodystrophy. Its label says it is not indicated for weight loss. Egrifta became a biologic (BLA) on March 23, 2020, and FDA says compounded versions of these products do not qualify for the 503A or 503B compounding exemptions.
CJC-1295/ipamorelin injection and tablets
A peptide blend this site does not cover.
GHK-Cu injection
GHK-Cu may be compounded only as a non-injected form. The cream and tablets are listed; the injection is not.
Sleep and sexual-performance tablets, and MIC B12
Products that are not peptides, so they fall outside what this site covers.

How it bills

Each product page offers monthly, three-month and six-month plans and a single starting price per month; the rates for the longer plans appear only after you create an account. Plans are subscriptions you can pause or cancel at any time, shipping is free, and HSA and FSA cards are accepted. Insurance is not taken. Refunds are loose. Before a clinician reviews you, you can ask to cancel; after approval or pharmacy processing, a refund may be limited or unavailable. A denial may bring a refund or an alternative, less any consultation or processing fees.

For and against

  • For: Sermorelin, NAD+ and GHK-Cu in several forms
  • For: Regular check-ins and unlimited messaging
  • For: Video visit available on request
  • For: HSA and FSA cards accepted
  • Against: No dose or schedule printed
  • Against: Prescribing clinicians are not named
  • Against: Outcome figures are its own surveys
  • Against: Refund terms are vague

The evidence behind what it sells

Right for

Readers who want sermorelin, NAD+ or GHK-Cu in a needle-free form, and who value regular check-ins over a detailed product page.

Look elsewhere if

Anyone who wants to see the dose, the prescriber or the plan rates before handing over an email address and medical history.

Other sellers for weight

Iron Med RX

Frequently asked questions

Does Iron Med RX say what dose of sermorelin or NAD+ you get?
No. Sermorelin is sold as low dose or high dose and NAD+ by a milligram total, but no page gives a dose per use or a schedule. The clinician sets it after your intake.
Will I talk to someone before Iron Med RX prescribes?
Not always. The intake is written, and a clinician may follow up with questions. A video visit is required in some states, and you can ask for one at no extra cost.
Can I get my money back from Iron Med RX?
Possibly, if you cancel before a clinician reviews you. Once your order is approved or at the pharmacy, a refund may be limited or unavailable.

See what Iron Med RX prescribes today

Iron Med RX sets its own prices, plans and the states it serves. Check them before you start.

Visit Iron Med RX →
Written by Molly Ward from Iron Med RX’s own public pages, against the published methodology. No outcome is claimed first-hand and no score is given. A partnership never changes what this page says; see how the site is paid. Last updated September 2026.